LFB is a bio-pharmaceutical company that develops, manufactures and markets plasma derived products and recombinant proteins for the treatment of patients with serious and often rare diseases. Founded in 1994 in France, LFB is one of the leading European bio-pharmaceutical companies providing mainly hospital-based healthcare professionals, with blood derived therapeutics with the vision to provide treatment options to patients in three major areas – immunology, haemostasias and intensive care.
LFB plasma donors are compensated for each donation. LFB states that being a regular plasma donor can be a fulfilling and rewarding experience for adults in good health between the ages of 18 and 65.
LFB Group currently markets 15 products in more than 30 countries.